With at least two in three Australians diagnosed with skin cancer before the age of 70, monitoring moles and skin is vital in detecting skin cancer early for a generation of people who spent much of their upbringing in the sun (often with little to no protection).
To meet the massive unmet need in this area, Research Professor at UniSA’s Future Industries Institute, Professor Tarl Prow led the team that has created a new needle device that will revolutionise how doctors test patients for rashes and diseases.
The microbiopsy device is a small needle that can take 100 to 200 cells to test for skin cancer and other diseases avoiding the need to take a 2cm to 3cm piece of tissue which results in some scarring.
Dr Prow says the device can take skin samples much more easily than a traditional biopsy and is easy and painless to use on children.
“The innovation for this device comes from the idea of a diabetic test. We can easily take small skin samples which makes it much easier to use on children and allows us to take multiple samples over time to monitor a patient’s situation,” Prof Prow says.
“Given a standard biopsy is a significant procedure, we wanted to help make that process easier.”
The device has already proved a possible game changer in underprivileged countries with doctors from Jerusalem’s Hebrew University already taking 502 units to Africa to use in the field.
“With many parasitic diseases in Africa, where people don’t have access to a hospital, researchers at Hebrew University undertook a study in northern Ethiopia testing hundreds of children and adults using the device,” he says.
With skin cancer a more prevalent problem in Australia, doctors can spend up a significant amount of time checking a patient’s skin (including moles and pink spots) and Dr Prow and his team are working on developing cancer biomarkers, so the device can take samples and evaluate (and reveal) the results instantly.
With clinical trials (unrelated to skin cancer) in the final stages, the team is monitoring feedback with thousands of devices already sold worldwide and is patented in the US, Australia and Europe.
“We are planning to test the efficacy and safety for microbiopsy in skin cancer diagnosis that will start in early 2019 so some patients may be asked to be a part of this study. We hope to launch the approved diagnostic test in 2023,” Dr Prow says.
The Latest on: Microbiopsy
via Google News
The Latest on: Microbiopsy
- Microbiopsy device samples skin cells for cancer without scarringon April 12, 2019 at 5:00 pm
Skin cancer is the most common form of the disease, and while it might make its presence known in the form of moles or strange spots, it usually takes a biopsy to confirm whether the mark is malignant ...
- Absorbent Microbiopsy Sampling and RNA Extraction for Minimally Invasive, Simultaneous Blood and Skin Analysison February 21, 2019 at 9:36 am
Skin biopsy is one of the most essential techniques in dermatology for skin sampling and subsequent diagnosis of skin diseases through histopathological assessment. The biopsy technique involves a ...
- DOE Patents Patent: Microbiopsy/precision cutting deviceson October 6, 2018 at 10:01 pm
Devices are disclosed for performing tissue biopsy on a small scale (microbiopsy). By reducing the size of the biopsy tool and removing only a small amount of tissue or other material in a minimally ...
- The Future of Skin Cancer Detection - Microbiopsieson April 17, 2018 at 5:30 am
"So the idea with the microbiopsy is we can go in on the face, on the head, where you don't want to have a surgical procedure, take a small sample and see whether or not it's malignant." Image source: ...
- Microbiopsy Needle for Pain- and Scar-free Skin Samplingon April 17, 2018 at 2:28 am
A painless, scar-free biopsy method offers a less invasive approach to collecting skin samples for the diagnosis Source: Tarl Prow, University of South Australiaof cancer and other diseases. The ...
- Microbiopsy engineered for minimally invasive and suture-free sub-millimetre skin samplingon July 12, 2017 at 5:00 pm
We describe the development of a sub-millimetre skin punch biopsy device for minimally invasive and suture-free skin sampling for molecular diagnosis and research. Conventional skin punch biopsies ...
- A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteerson May 8, 2017 at 5:00 pm
Run-in Phase: All participants will receive oral deuterated water (D2O) for 3 weeks prior to the Treatment Phase of the study. The participants will consume 50mL 70% D2O three times per day (TID) for ...
- A Microbiopsy Method for Immunohistological and Morphological Analysis: A Pilot Studyon January 1, 2017 at 4:00 pm
Introduction: The fine aspiration microbiopsy is a relatively new biopsy technique, which allows muscle physiologists to sample skeletal muscle less invasively. However, the small sample size obtained ...
- Mitochondrial Bioenergetics and Fiber Type Assessments in Microbiopsy vs. Bergstrom Percutaneous Sampling of Human Skeletal Muscleon November 14, 2016 at 4:00 pm
Microbiopsies of human skeletal muscle are increasingly adopted by physiologists for a variety of experimental assays given the reduced invasiveness of this procedure compared to the classic Bergstrom ...
via Bing News